Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic moderate to severe low back pain: A randomized, double-blind study

Journal of Pain

Volumn 12, Issue 11, 2011, Pages 1163-1173

  Steiner, Deborah ^a   Munera, Catherine ^a   Hale, Martin ^b   Ripa, Steven ^a   Landau, Craig ^a  

^a PURDUE PHARMA L P   (United States)

^b Gold Coast Research   (United States)

Author keywords

analgesia; Back pain; opioids; pain; transdermal buprenorphine

Indexed keywords

BUPRENORPHINE; OXYCODONE;

ADULT; ARTICLE; CHRONIC DISEASE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG FATALITY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXPLORATORY RESEARCH; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; INCIDENCE; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM DISEASE; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SENSITIVITY ANALYSIS; SKIN DISEASE; THORAX DISEASE; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; ANALGESICS, OPIOID; BUPRENORPHINE; CHRONIC PAIN; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LOW BACK PAIN; MALE; MIDDLE AGED; OXYCODONE; TRANSDERMAL PATCH; TREATMENT OUTCOME;

EID: 80054886802     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2011.06.003     Document Type: Article

References (22)

1. Butrans [package insert]. Stamford, CT. Purdue Pharma LP, 2010
2. R. Chou, G.J. Fanciullo, P.G. Fine, J.A. Adler, J.C. Ballantyne, P. Davies, M.I. Donovan, D.A. Fishbain, K.M. Foley, J. Fudin, A.M. Gilson, A. Kelter, A. Mauskop, P.G. O'Connor, S.D. Passik, G.W. Pasternak, R.K. Portenoy, B.A. Rich, R.G. Roberts, K.H. Todd, C. Miaskowski American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel Opioid treatment guidelines: Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain J Pain 10 2009 113 130
3. R. Chou, A. Qaseem, V. Snow, D. Casey, J.T. Cross Jr., P. Shekelle, D.K. Owens Clinical Efficacy Assessment Subcommittee of the American College of Physicians and the American College of Physicians/American Pain Society Low Back Pain Guidelines Panel Diagnosis and treatment of low back pain: A joint clinical practice guideline from the American College of Physicians and the American Pain Society Ann Intern Med 147 2007 478 491 (Pubitemid 351688341)
4. Deshpande A, Furlan AD, Mailis-Gagnon A, Atlas S, Turk D. Opioids for chronic low-back pain. Cochrane Database of Systematic Reviews Issue 3. Art. No.: CD004959. DOI: 10.1002/14651858.CD004959.pub3, 2007
5. R.H. Dworkin, D.C. Turk, K.W. Wyrwich, D. Beaton, C.S. Cleeland, J.T. Farrar, J.A. Haythornthwaite, M.P. Jensen, R.D. Kerns, D.N. Ader, N. Brandenburg, L.B. Burke, D. Cella, J. Chandler, P. Cowan, R. Dimitrova, R. Dionne, S. Hertz, A.R. Jadad, N.P. Katz, H. Kehlet, L.D. Kramer, D.C. Manning, C. McCormick, M.P. McDermott, H.J. McQuay, S. Patel, L. Porter, S. Quessy, B.A. Rappaport, C. Rauschkolb, D.A. Revicki, M. Rothman, K.E. Schmader, B.R. Stacey, J.W. Stauffer, T. von Stein, R.E. White, J. Witter, and S. Zavisic Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations J Pain 9 2008 105 121 (Pubitemid 351147828)
6. J.C.T. Fairbank, and P.B. Pynsent The Oswestry Disability Index Spine 25 2000 2940 2953
7. J.T. Farrar, J.P. Young Jr., L. LaMoreaux, J.L. Werth, and R.M. Poole Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale Pain 94 2001 149 158 (Pubitemid 33016608)
8. T.R. Fleming Addressing missing data in clinical trials Ann Intern Med 154 2011 113 117
9. R.D. Hays, and A.L. Stewart Sleep measures A.L. Stewart, J.E. Ware Jr. Measuring Functioning and Well-Being: The Medical Outcomes Study Approach 1992 Duke University Press Durham, NC 235 259
10. S. Holm A simple sequentially rejective test procedure Scand J Stat 6 1979 65 70
11. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use: ICH Topic E 9: Statistical principles for clinical trials. Available at: http://www.fda.gov/downloads/ Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm073137.pdf. Accessed October 19, 2010
12. R.E. Johnson, P.J. Fudala, and R. Payne Buprenorphine: Considerations for pain management J Pain Symptom Manage 29 2005 297 326 (Pubitemid 40386746)
13. E. Kalso, L. Allan, J. Dobrogowski, M. Johnson, N. Krcevski-Skvarc, G.J. Macfarlane, G. Mick, S. Ortolani, S. Perrot, A. Perucho, I. Semmons, and J. Sörensen Do strong opioids have a role in the early management of back pain? Recommendations from a European expert panel Curr Med Res Opin 21 2005 1819 1828 (Pubitemid 41667250)
14. C.J. Landau, W.D. Carr, A.J. Razzetti, N.E. Sessler, C. Munera, and S.R. Ripa Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: A multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study Clin Ther 29 2007 2179 2193 (Pubitemid 350148284)
15. H.J. McQuay, S. Derry, R.A. Moore, P. Poulain, and V. Legout Enriched enrolment with randomized withdrawal (EERW): Time for a new look at clinical trial design in chronic pain Pain 135 2008 217 220
16. C. Munera, M. Drehobl, N.E. Sessler, and C. Landau A randomized, placebo-controlled, double-blinded, parallel-group, 5-week study of buprenorphine transdermal system in adults with osteoarthritis J Opioid Manag 6 2010 193 202
17. S. Negrini, C. Fusco, S. Atanasio, M. Romano, and F. Zaina Low back pain: State of art Eur J Pain Suppl. 2 2008 52 56
18. The Prevention and Treatment of Missing Data in Clinical Trials: Panel on Handling Missing Data in Clinical Trials 2010 National Research Council, The National Academies Press Washington, DC pp 3
19. S.N. Quessy Two-stage enriched enrolment pain trials: A brief review of designs and opportunities for broader application Pain 148 2010 8 13
20. Safety and Efficacy of Buprenorphine Transdermal Delivery System in Subjects With Moderate to Severe Low Back Pain. Available at http://www.clinicaltrials.gov/ct2/show/NCT00313014?term=BTDS&age= 1&phase=2&fund=2&rank=6. Accessed October 19, 2010
21. D. Steiner, C. Munera, M. Hale, S. Ripa, and C. Landau The efficacy and safety of buprenorphine transdermal system (BTDS) in subjects with moderate to severe low back pain: A double-blind study J Pain 10 2009 S51
22. A.M. Trescot, S. Helm, H. Hansen, R. Benyamin, S.E. Glaser, R. Adlaka, S. Patel, and L. Manchikanti Opioids in the management of chronic non-cancer pain: An update of the American Society of the Interventional Pain Physicians' (ASIPP) guidelines Pain Physician 11 2008 S5 S62